Hospital Universitario de Canarias, San Cristóbal de La Laguna, Tenerife, Spain -
Department of Computer Science and System Engineering, Universidad de La Laguna (ULL), San Cristóbal de La Laguna, Tenerife, Spain.
Minerva Anestesiol. 2019 Jun;85(6):585-593. doi: 10.23736/S0375-9393.18.13058-6. Epub 2018 Oct 30.
Delay in the propofol pharmacodynamics effect is commonly observed in total intravenous anesthesia (TIVA). To face the delay in the hypnosis control, we have proposed a proportional-integral (PI) controller with a Smith predictor (PI+Smith). We have evaluated the feasibility of this closed-loop control for propofol administration and compared the performance with manual administration guided by the Bispectral Index (BIS).
Fifty-seven adult patients under TIVA with propofol and remifentanil were randomly assigned to a PI+Smith or a manual control (MC) group. The BIS target was set to 50. The performance was compared through the global score (GS), median performance error (MDPE), median absolute performance error (MDAPE), offset and Wobble.
A total of 29 patients in the MC and 25 in the PI+Smith groups completed this study. Performance was significantly better in the PI+Smith group: global score was 25 (19 to 37) for PI+Smith versus 44 (32 to 57) for MC (P<0.001); MDPE was -0.9 (-5.6 to 2) for PI+Smith versus -11 (-16 to -4.3) for MC (P<0.001); MDAPE was 10.8 (8.8 to 14.3) for PI+Smith versus 17 (12.8 to 19.2) for MC (P<0.001); offset was -0.6 (-3.2 to 0.06) for PI+Smith versus -3.7 (-7.0 to -0.8) for MC (P=0.01). The percentage time of BIS within the 40-60 range during the maintenance phase was higher in the PI+Smith group 80.8 (68.7 to 87.9) than in the MC group 59.1 (53.4 to 72.5) (P<0.001).
The use of a specific mechanism in the PI controller to deal with the delay outperformed satisfactorily manual practice. The controller was able to regulate propofol administration, maintaining the BIS value within a desirable range and coping with oscillations.
全凭静脉麻醉(TIVA)中常观察到异丙酚药效动力学效应的延迟。为了应对催眠控制的延迟,我们提出了一种带有史密斯预估器的比例积分(PI)控制器(PI+Smith)。我们评估了这种闭环控制用于异丙酚给药的可行性,并与 BIS 引导的手动给药进行了比较。
57 例 TIVA 下接受异丙酚和瑞芬太尼的成年患者被随机分配到 PI+Smith 或手动控制(MC)组。BIS 目标设定为 50。通过总评分(GS)、中位性能误差(MDPE)、中位绝对性能误差(MDAPE)、偏移量和摆动来比较性能。
MC 组共有 29 例,PI+Smith 组 25 例完成了这项研究。PI+Smith 组的性能明显更好:PI+Smith 组的总评分是 25(19 至 37),而 MC 组是 44(32 至 57)(P<0.001);MDPE 为 -0.9(-5.6 至 2),而 MC 组为 -11(-16 至 -4.3)(P<0.001);MDAPE 为 10.8(8.8 至 14.3),而 MC 组为 17(12.8 至 19.2)(P<0.001);偏移量为 -0.6(-3.2 至 0.06),而 MC 组为 -3.7(-7.0 至 -0.8)(P=0.01)。在维持阶段,PI+Smith 组 BIS 在 40-60 范围内的时间百分比为 80.8(68.7 至 87.9),高于 MC 组的 59.1(53.4 至 72.5)(P<0.001)。
PI 控制器中使用特定机制来处理延迟,性能优于手动操作。该控制器能够调节异丙酚给药,使 BIS 值保持在理想范围内,并应对波动。